Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

for
Ductal Carcinoma in Situ
Location: Washington D.C. DC, Richmond VA, New York NY,
Sponsor: QuantumLeap Healthcare Collaborative

Sex: Female

Age: 18+

Code: NCT06075953

Phase 2, Recruiting
Active & Responsive

Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Washington D.C. DC, Hershey PA, Charlottesville VA,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT05338697

Recruiting
Active & Responsive

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

for
Heart Failure, Heart Diseases, Cardiovascular Diseases,
Location: Washington D.C. DC, Hershey PA, Richmond VA,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT06526195

Recruiting
Active & ResponsiveNew

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study

for
Venous Thromboses, Venous Disease, Venous Leg Ulcer,
Location: Washington D.C. DC, Darien CT, Dallas TX, Seattle WA
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18+

Code: NCT07538609

Recruiting
Active & Responsive

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

for
AAA, AAA - Abdominal Aortic Aneurysm
Location: Washington D.C. DC, Philadelphia PA, Allentown PA,
Sponsor: Endologix

Sex: All

Age: 21+

Code: NCT05064540

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

for
Non-small Cell Lung Cancer, NSCLC
Location: Washington D.C. DC, Philadelphia PA, Bethlehem PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06422143

Phase 3, Recruiting
Active & Responsive

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

for
Advanced Breast Cancer, Early Breast Cancer
Location: Washington D.C. DC, Hershey PA, Bethlehem PA,
Sponsor: TerSera Therapeutics LLC

Sex: Female

Age: 18 - 55

Code: NCT07310420

Phase 1, Recruiting
Active & Responsive

A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer

for
IO Resistant Squamous and Nonsquamous NSCLC
Location: Washington D.C. DC, New York NY, Knoxville TN,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07217301

Phase 3, Recruiting
Active & Responsive

SNS and PrEP Initiation and Adherence in Black SMM

for
HIV
Location: Washington DC
Sponsor: Us Helping Us, People Into Living, Inc.

Sex: Male

Age: 18+

Code: NCT05499962

Recruiting
Active & Responsive

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

for
Metastatic Castrate Resistant Prostate Cancer,
Location: Washington D.C. DC, Philadelphia PA, New York NY,
Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT04038502

Phase 2, Recruiting
Active & Responsive

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

for
Prostate Cancer, Prostatic Neoplasms
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: Male

Age: 18+

Code: NCT06925737

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Washington D.C. DC, Bethesda MD, Baltimore MD,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase 3, Recruiting
Active & Responsive

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

for
Opioid Use Disorder, Opioid Use Disorder, Severe,
Location: Washington D.C. DC, Greenville SC, Milwaukee WI,
Sponsor: Montefiore Medical Center

Sex: All

Age: 18+

Code: NCT07631598

Recruiting
Active & Responsive

Sensory Feedback and Hand Motor Adaptation

for
Stroke
Location: Washington D.C. DC
Sponsor: The Catholic University of America

Sex: All

Age: 20 - 70

Code: NCT07598695

Early Phase 1, Recruiting
Active & ResponsiveNew

Dietary Intervention for Migraine Relief

for
Migraine
Location: Washington D.C. DC
Sponsor: American University

Sex: All

Age: 18 - 70+

Code: NCT07360405

Recruiting
Active & Responsive

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

for
HIV
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: ViiV Healthcare

Sex: All

Age: 12+

Code: NCT07650916

Phase 3, Recruiting
Active & Responsive

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

for
Solid Tumor
Location: Washington D.C. DC, Fairfax VA, Philadelphia PA,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06384807

Phase 1, Phase 2, Recruiting
Active & Responsive

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

for
Diabetic Peripheral Neuropathic Pain
Location: Washington D.C. DC, Rockville MD, Norfolk VA,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07231419

Phase 3, Recruiting
Active & Responsive

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

for
Generalized Myasthenia Gravis
Location: Washington D.C. DC, Philadelphia PA, New Hyde Park NY,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT04202341

Recruiting